The dramatic downregulation of THSD4, LEFTY2, and LTBP1 induced by melphalan treatment could collectively enhance the activation of TGF-β signaling pathway [41] and impact the downstream cellular processes such as the induction of apoptosis as observed in myocardial infarction [42]. Here, THSD4 is linked to myocardial infarction.